MDC Partners Inc. Class A
Find Ratings ReportsMDC PARTNERS INC's gross profit margin for the third quarter of its fiscal year 2020 has increased when compared to the same period a year ago. Even though sales decreased, the net income has increased. MDC PARTNERS INC has weak liquidity. Currently, the Quick Ratio is 0.67 which shows a lack of ability to cover short-term cash needs. The liquidity decreased from the same period a year ago, despite already having weak liquidity to begin with. This would indicate deteriorating cash flow.
At the same time, stockholders' equity ("net worth") has remained virtually unchanged only increasing by 1.63% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is in a position in which financial difficulties could develop in the future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
Income Statement | Q3 FY20 | Q3 FY19 |
---|---|---|
Net Sales ($mil) | 283.42 | 342.91 |
EBITDA ($mil) | 41.18 | 42.68 |
EBIT ($mil) | 31.85 | 33.31 |
Net Income ($mil) | 4.08 | -1.75 |
Balance Sheet | Q3 FY20 | Q3 FY19 |
---|---|---|
Cash & Equiv. ($mil) | 37.08 | 27.28 |
Total Assets ($mil) | 1706.13 | 1751.73 |
Total Debt ($mil) | 1157.57 | 1173.31 |
Equity ($mil) | -210.74 | -214.25 |
Profitability | Q3 FY20 | Q3 FY19 |
---|---|---|
Gross Profit Margin | 39.13 | 35.13 |
EBITDA Margin | 14.53 | 12.44 |
Operating Margin | 11.24 | 9.71 |
Sales Turnover | 0.73 | 0.81 |
Return on Assets | -0.15 | -4.51 |
Return on Equity | 0.0 | 0.0 |
Debt | Q3 FY20 | Q3 FY19 |
---|---|---|
Current Ratio | 0.77 | 0.72 |
Debt/Capital | 1.22 | 1.22 |
Interest Expense | 15.27 | 16.11 |
Interest Coverage | 2.09 | 2.07 |
Share Data | Q3 FY20 | Q3 FY19 |
---|---|---|
Shares outstanding (mil) | 73.56 | 72.15 |
Div / share | 0.0 | 0.0 |
EPS | 0.0 | -0.07 |
Book value / share | -2.87 | -2.97 |
Institutional Own % | n/a | n/a |
Avg Daily Volume | 167182.0 | 116754.0 |
SELL. This stock’s P/E ratio is negative, making its value useless in the assessment of premium or discount valuation, only displaying that the company has negative earnings per share. Along with this, the price-to-book ratio is also meaningless due to a negative book value for the company, making any comparisons useless. The price-to-sales ratio is well below both the S&P 500 average and the subsector average, indicating a discount.
Price/Earnings |
|
Price/Cash Flow |
| |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDCA NM | Peers 47.01 | MDCA 2.53 | Peers 9.85 | |||||||||||||||||||||
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings. MDCA's P/E is negative making this valuation measure meaningless. |
Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures. MDCA is trading at a significant discount to its peers. |
|||||||||||||||||||||||
Price/Projected Earnings |
|
Price to Earnings/Growth |
|
|||||||||||||||||||||
MDCA NA | Peers 23.72 | MDCA NA | Peers 1.99 | |||||||||||||||||||||
Neutral. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth potential. Ratio not available. |
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples. Ratio not available. |
|||||||||||||||||||||||
Price/Book |
|
Earnings Growth |
|
|||||||||||||||||||||
MDCA NM | Peers 3.03 | MDCA 84.62 | Peers 6.28 | |||||||||||||||||||||
Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet. MDCA's P/B is negative making this valuation measure meaningless. |
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios. MDCA is expected to have an earnings growth rate that significantly exceeds its peers. |
|||||||||||||||||||||||
Price/Sales |
|
Sales Growth |
|
|||||||||||||||||||||
MDCA 0.18 | Peers 140.48 | MDCA -12.24 | Peers 1.83 | |||||||||||||||||||||
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales. MDCA is trading at a significant discount to its subsector on this measurement. |
Lower. A sales growth rate that trails the subsector implies that a company is losing market share. MDCA significantly trails its peers on the basis of sales growth. |
|||||||||||||||||||||||